Clinical uses of nalidixic acid analogues: the fluoroquinolones
- 1 April 1986
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 5 (2) , 138-140
- https://doi.org/10.1007/bf02013968
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistanceJournal of Antimicrobial Chemotherapy, 1986
- Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1986
- Elimination of plasmids by new 4-quinolonesAntimicrobial Agents and Chemotherapy, 1985
- Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strainsAntimicrobial Agents and Chemotherapy, 1985
- Ciprofloxacin for Selective Decontamination of the Alimentary Tract in Patients with Acute Leukemia During Remission Induction Treatment: The Effect on Fecal FloraThe Journal of Infectious Diseases, 1985
- CIPROFLOXACIN-RESISTANT PSEUDOMONASThe Lancet, 1985
- CLINICAL RESISTANCE TO LONG-TERM ORAL CIPROFLOXACINThe Lancet, 1985
- USE OF ENOXACIN IN A PATIENT WITH CYSTIC FIBROSISThe Lancet, 1985
- Mutational resistance to 4-quinolone antibacterial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Treatment of Penicillin-ResistantNeisseria gonorrhoeaewith Oral NorfloxacinNew England Journal of Medicine, 1984